Purpose: Although survival of encapsulated thymomas is usually good, some patients present a higher incidence rate of recurrence and a shorter long-term survival. Abnormalities in the components of cell cycle checkpoints are extremely common among virtually all neoplasms. In this study, three components of the cell cycle machinery (i.e., p21, p27 and p53) were examined in a series of well-characterized encapsulated thymoma specimens to analyze coregulation and influence on recurrence and survival. Experimental Design: Sixty-eight consecutive patients with thymoma were operated in our center from 1987 to 2000. Expression of p53, p21, and p27 was studied in specimens from 25 encapsulated thymomas using immunohistochemistry. Generic factors and gene expression influencing the probability of recurrence were studied. Positive expression was dichotomized defining positive when present in more than 5% of tumor cells. Mean follow up was 85.9 months; clinical data about recurrence were recorded. Results: Univariate analysis suggests that positive p53 (P < 0.05), negative p21 (P = 0.01), and especially negative p27 expressions (P = 0.001) significantly correlate with poor prognosis for disease-free survival. Multivariate Cox regression analysis suggests that negative p27 immunohistology is the only significant variable for poor prognosis (P = 0.03; odds ratio, 0.08; 95% confidence interval, 0.01 - 0.88). Conclusions: These results show that loss of control of cell cycle checkpoints is a common occurrence in thymomas and support the idea that functional cooperation between different cell cycle inhibitor proteins constitutes another level of regulation in cell growth control and tumor suppression.

Baldi, A., Ambrogi, V., Mineo, D., Mellone, P., Campioni, M., Citro, G., et al. (2005). Analysis of cell cycle regulator proteins in encapsulated thymomas. CLINICAL CANCER RESEARCH, 11(14), 5078-5083 [10.1158/1078-0432.CCR-05-0070].

Analysis of cell cycle regulator proteins in encapsulated thymomas

AMBROGI, VINCENZO;MINEO, DAVIDE;MINEO, TOMMASO CLAUDIO
2005-01-01

Abstract

Purpose: Although survival of encapsulated thymomas is usually good, some patients present a higher incidence rate of recurrence and a shorter long-term survival. Abnormalities in the components of cell cycle checkpoints are extremely common among virtually all neoplasms. In this study, three components of the cell cycle machinery (i.e., p21, p27 and p53) were examined in a series of well-characterized encapsulated thymoma specimens to analyze coregulation and influence on recurrence and survival. Experimental Design: Sixty-eight consecutive patients with thymoma were operated in our center from 1987 to 2000. Expression of p53, p21, and p27 was studied in specimens from 25 encapsulated thymomas using immunohistochemistry. Generic factors and gene expression influencing the probability of recurrence were studied. Positive expression was dichotomized defining positive when present in more than 5% of tumor cells. Mean follow up was 85.9 months; clinical data about recurrence were recorded. Results: Univariate analysis suggests that positive p53 (P < 0.05), negative p21 (P = 0.01), and especially negative p27 expressions (P = 0.001) significantly correlate with poor prognosis for disease-free survival. Multivariate Cox regression analysis suggests that negative p27 immunohistology is the only significant variable for poor prognosis (P = 0.03; odds ratio, 0.08; 95% confidence interval, 0.01 - 0.88). Conclusions: These results show that loss of control of cell cycle checkpoints is a common occurrence in thymomas and support the idea that functional cooperation between different cell cycle inhibitor proteins constitutes another level of regulation in cell growth control and tumor suppression.
2005
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/21 - CHIRURGIA TORACICA
English
Con Impact Factor ISI
cell cycle protein; protein p21; protein p27; protein p53; adolescent; adult; aged; article; cancer recurrence; cancer survival; cell cycle; cell growth; clinical article; controlled study; correlation analysis; encapsulation; female; follow up; gene expression; human; human cell; immunohistochemistry; male; priority journal; prognosis; protein analysis; protein expression; protein function; recurrence risk; thymoma; Adolescent; Adult; Aged; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Female; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Analysis; Thymoma; Thymus Neoplasms; Tumor Suppressor Protein p53; Tumor Suppressor Proteins
Baldi, A., Ambrogi, V., Mineo, D., Mellone, P., Campioni, M., Citro, G., et al. (2005). Analysis of cell cycle regulator proteins in encapsulated thymomas. CLINICAL CANCER RESEARCH, 11(14), 5078-5083 [10.1158/1078-0432.CCR-05-0070].
Baldi, A; Ambrogi, V; Mineo, D; Mellone, P; Campioni, M; Citro, G; Mineo, Tc
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/32368
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 11
social impact